Paypal Cash on Delivery (COD) Cash in Advance (CID) Western Union
Contact us for information regarding our sample policy
Asia Australia Central America North America Western Europe Middle East Africa South America Eastern Europe
All India
Product Description
Daclatasvir/sofosbuvir is a two-drug combination for the treatment of hepatitis C. The same combination is produced by Aprazer Health Care under the trade name of Sofokast Plus. It is given as a single pill containing daclatasvir, the viral NS5A inhibitor and sofosbuvir, a nucleotide inhibitor of the viral RNA polymerase. The combination includes 400 mg sofosbuvir and 60 mg daclatasvir and has been used in clinical trials since 2015